Celltrion
068270.KS
#679
Rank
S$46.29 B
Marketcap
S$203.05
Share price
-0.47%
Change (1 day)
30.70%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2023 (TTM): S$4.08

According to Celltrion 's latest financial reports the company's current EPS (TTM) is S$4.17. In 2022 the company made an earnings per share (EPS) of S$3.73 a decrease over its 2021 EPS that were of S$4.43.

EPS history for Celltrion from 2007 to 2023

Annual EPS

Year EPS Change
2023 (TTM)S$4.089.53%
2022S$3.73-15.84%
2021S$4.4312.77%
2020S$3.9370.79%
2019S$2.3015.63%
2018S$1.99-33.13%
2017S$2.98141.17%
2016S$1.238.28%
2015S$1.1411.28%
2014S$1.0216.37%
2013S$0.88-67.42%
2012S$2.7084.22%
2011S$1.4762.13%
2010S$0.9080.61%
2009S$0.50-559.63%
2008S-$0.11-123.16%
2007S$0.47